Parathyroid hormone–related peptide and survival of patients with cancer and hypercalcemia
NU Truong, MDB Edwardes, V Papavasiliou… - The American journal of …, 2003 - Elsevier
PURPOSE: Parathyroid hormone–related peptide (PTHrP) is the predominant cause of
malignancy-associated hypercalcemia. However, its prognostic utility is unclear. We aimed
to determine the prognostic value of serum PTHrP levels in patients who had hypercalcemia
associated with malignancy. METHODS: In this prospective case series, we evaluated 76
patients with a diagnosis of cancer and hypercalcemia (serum calcium level≥ 10.3 mg/dL
on at least two occasions). PTHrP levels≥ 1 pmol/L were considered elevated. We used …
malignancy-associated hypercalcemia. However, its prognostic utility is unclear. We aimed
to determine the prognostic value of serum PTHrP levels in patients who had hypercalcemia
associated with malignancy. METHODS: In this prospective case series, we evaluated 76
patients with a diagnosis of cancer and hypercalcemia (serum calcium level≥ 10.3 mg/dL
on at least two occasions). PTHrP levels≥ 1 pmol/L were considered elevated. We used …
